FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Insmed’s ASCEND Study and INS1201, an Investigational Gene Therapy for Duchenne Muscular Dystrophy

Activity Snapshot

Activity Type: 
Live, Virtual Webinar
Release Date: 
Tuesday, December 9, 2025
Register
Activity Overview: 

10:00 AM in Arizona